{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:06:15Z","timestamp":1790417175386,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":693,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:p> <jats:bold>Abstract:<\/jats:bold> Mutations in \u03b1\u2010synuclein cause a form of familial Parkinson\u2019s disease (PD), and wild\u2010type \u03b1\u2010synuclein is a major component of the intraneuronal inclusions called Lewy bodies, a pathological hallmark of PD. These observations suggest a pathogenic role for \u03b1\u2010synuclein in PD. Thus far, however, little is known about the importance of \u03b1\u2010synuclein in the nigral dopaminergic pathway in either normal or pathological situations. Herein, we studied this question by assessing the expression of synuclein\u20101, the rodent homologue of human \u03b1\u2010synuclein, in both normal and 1\u2010methyl\u20104\u2010phenyl\u20101,2,3,6\u2010tetrahydropyridine (MPTP)\u2010intoxicated mice. In normal mice, detectable levels of synuclein mRNA and protein were seen in all brain regions studied and especially in ventral midbrain. In the latter, there was a dense synuclein\u2010positive nerve fiber network, which predominated over the substantia nigra, and only few scattered synuclein\u2010positive neurons. After a regimen of MPTP that kills dopaminergic neurons by apoptosis, synuclein mRNA and protein levels were increased significantly in midbrain extracts; the time course of these changes paralleled that of MPTP\u2010induced dopaminergic neurodegeneration. In these MPTP\u2010injected mice, there was also a dramatic increase in the number of synuclein\u2010immunoreactive neurons exclusively in the substantia nigra pars compacta; all synuclein\u2010positive neurons were tyrosine hydroxylase\u2010positive, but none coexpressed apoptotic features. These data indicate that synuclein is highly expressed in the nigrostriatal pathway of normal mice and that it is up\u2010regulated following MPTP\u2010induced injury. In light of the synuclein alterations, it can be suggested that, by targeting this protein, one may modulate MPTP neurotoxicity and, consequently, open new therapeutic avenues for PD.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2000.740721.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:43:45Z","timestamp":1047451425000},"page":"721-729","source":"Crossref","is-referenced-by-count":329,"title":["\u03b1\u2010Synuclein Up\u2010Regulation in Substantia Nigra Dopaminergic Neurons Following Administration of the Parkinsonian Toxin MPTP"],"prefix":"10.1111","volume":"74","author":[{"given":"Miquel","family":"Vila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slobodanka","family":"Vukosavic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vernice","family":"Jackson\u2010Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Neystat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jakowec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Przedborski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410440719"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(08)61933-0"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(97)01213-7"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.3.CO;2-I"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/3311"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19961111)375:2<167::AID-CNE1>3.3.CO;2-0"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01419-7"},{"key":"e_1_2_10_9_2","first-page":"87","article-title":"Alpha\u2010synuclein interacts in vivo with another protein (synphilin 1).","volume":"13","author":"Engelender S.","year":"1998","journal-title":"Mov. Disord."},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/8820"},{"key":"e_1_2_10_11_2","unstructured":"FahnS.(1988)Parkinsonism inCecil\u2019s Textbook of Medicine(Wyngaarden J. B. and Smith L. H. Jr. eds) pp.2143\u20132147.Saunders Philadelphia."},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)91111-0"},{"key":"e_1_2_10_13_2","unstructured":"FranklinK.B.J.&PaxinosG.(1997)The Mouse Brain in Stereotaxic Coordinates. Academic Press San Diego."},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90040-3"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.12.7619"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199901)14:1<6::AID-MDS1004>3.0.CO;2-L"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-199903170-00011"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(91)90180-V"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-199608000-00004"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(95)90302-X"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(96)00014-5"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/1055-8330(95)90015-2"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi972776r"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71062634.x"},{"key":"e_1_2_10_25_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mla30Pro mutation in the gene encoding \u03b1\u2010synuclein in Parkinson\u2019s  disease.","volume":"18","author":"Kruger R.","year":"1998","journal-title":"Nat. Genet."},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.8.9.871"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.10.5774"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0169-328X(91)90043-W"},{"key":"e_1_2_10_29_2","first-page":"201","article-title":"Altered presynaptic protein NACP is associated with plaque  formation and neurodegeneration in Alzheimer\u2019s disease.","volume":"148","author":"Masliah E.","year":"1996","journal-title":"Am. J. Pathol."},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.20.1.245"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.14.9843"},{"key":"e_1_2_10_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-3806(96)00173-3"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.14.030191.002321"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(98)00596-X"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2045"},{"key":"e_1_2_10_36_2","first-page":"35","article-title":"Mechanisms of MPTP toxicity.","volume":"13","author":"Przedborski S.","year":"1998","journal-title":"Mov. Disord."},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.10.4565"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"e_1_2_10_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.11.6469"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1177\/002215549704500107"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4522(96)00545-3"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb10991.x"},{"key":"e_1_2_10_43_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.23.11282"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-3806(96)00210-6"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2000.740721.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2000.740721.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T15:50:30Z","timestamp":1698594630000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2000.740721.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1471-4159.2000.740721.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2000.740721.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}